chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Gastrointestinal disorder, Vomiting
Clinical narrative: decreased appetite; GI symptoms starting 30-40 minutes after the injection; patient had to pull-over his car to the side of the road to vomit/proceeded to vomit multiple times that day; diarrhea; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (diarrhea), DECREASED APPETITE (decreased appetite), GASTROINTESTINAL DISORDER (GI symptoms starting 30-40 minutes after the injection) and VOMITING (patient had to pull-over his car to the side of the road to vomit/proceeded to vomit multiple times that day) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced DIARRHOEA (diarrhea), GASTROINTESTINAL DISORDER (GI symptoms starting 30-40 minutes after the injection) and VOMITING (patient had to pull-over his car to the side of the road to vomit/proceeded to vomit multiple times that day). On 02-Feb-2021, the patient experienced DECREASED APPETITE (decreased appetite). At the time of the report, DIARRHOEA (diarrhea), DECREASED APPETITE (decreased appetite), GASTROINTESTINAL DISORDER (GI symptoms starting 30-40 minutes after the injection) and VOMITING (patient had to pull-over his car to the side of the road to vomit/proceeded to vomit multiple times that day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Headache, Nausea
Clinical narrative: Diarrhea; Chills; Fatigue; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), CHILLS (Chills), FATIGUE (Fatigue), HEADACHE (Headache) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea), CHILLS (Chills), FATIGUE (Fatigue), HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, DIARRHOEA (Diarrhea), CHILLS (Chills), FATIGUE (Fatigue), HEADACHE (Headache) and NAUSEA (Nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Dizziness, Nausea, Pain
Clinical narrative: experienced dizziness like he was going to fall/the dizziness "felt like a stroke"; nausea; vomiting; diarrhea; soreness; didn't want to eat; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of NAUSEA (nausea), VOMITING (vomiting), DIARRHOEA (diarrhea), PAIN (soreness) and DECREASED APPETITE (didn't want to eat) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (in November 2020. He stated that he was sick from COVID-19 for 2.5 weeks.) in November 2020. Concurrent medical conditions included Renal disease (Moderate renal disease), Drug allergy (Sulfa) and Drug allergy (Flexeril). Concomitant products included POTASSIUM CITRATE, SODIUM BICARBONATE, CALCIUM and VITAMIN D NOS for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced NAUSEA (nausea), VOMITING (vomiting), DIARRHOEA (diarrhea), PAIN (soreness) and DECREASED APPETITE (didn't want to eat). On 02-Feb-2021, the patient experienced DIZZINESS (experienced dizziness like he was going to fall/the dizziness "felt like a stroke"). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) at an unspecified dose and frequency. At the time of the report, NAUSEA (nausea) had not resolved and VOMITING (vomiting), DIARRHOEA (diarrhea), PAIN (soreness), DECREASED APPETITE (didn't want to eat) and DIZZINESS (experienced dizziness like he was going to fall/the dizziness "felt like a stroke") was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 2 Feb 2021, the patient reported that he feels better but still feels queasy and is not working today.   Reporter did not allow further contact
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: experienced dizziness like he was going to fall/the dizziness "felt like a stroke"; nausea; vomiting; diarrhea; soreness; didn't want to eat; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of NAUSEA (nausea), VOMITING (vomiting), DIARRHOEA (diarrhea), PAIN (soreness) and DECREASED APPETITE (didn't want to eat) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (in November 2020. He stated that he was sick from COVID-19 for 2.5 weeks.) in November 2020. Concurrent medical conditions included Renal disease (Moderate renal disease), Drug allergy (Sulfa) and Drug allergy (Flexeril). Concomitant products included POTASSIUM CITRATE, SODIUM BICARBONATE, CALCIUM and VITAMIN D NOS for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced NAUSEA (nausea), VOMITING (vomiting), DIARRHOEA (diarrhea), PAIN (soreness) and DECREASED APPETITE (didn't want to eat). On 02-Feb-2021, the patient experienced DIZZINESS (experienced dizziness like he was going to fall/the dizziness "felt like a stroke"). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) at an unspecified dose and frequency. At the time of the report, NAUSEA (nausea) had not resolved and VOMITING (vomiting), DIARRHOEA (diarrhea), PAIN (soreness), DECREASED APPETITE (didn't want to eat) and DIZZINESS (experienced dizziness like he was going to fall/the dizziness "felt like a stroke") was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 2 Feb 2021, the patient reported that he feels better but still feels queasy and is not working today.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy, Pain, Vaccination site pain
Clinical narrative: pain down left side; SWOLLEN LYMPH NODE IN ARM, SWOLLEN LYMPH NODE IN JAW; feeling run down; ARM SORENESS; FATIGUE; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE PAIN (ARM SORENESS), FATIGUE (FATIGUE), LYMPHADENOPATHY (SWOLLEN LYMPH NODE IN ARM, SWOLLEN LYMPH NODE IN JAW), FATIGUE (feeling run down) and PAIN (pain down left side) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L201A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 21-Jan-2021, the patient experienced VACCINATION SITE PAIN (ARM SORENESS) and FATIGUE (FATIGUE). On 27-Jan-2021, the patient experienced LYMPHADENOPATHY (SWOLLEN LYMPH NODE IN ARM, SWOLLEN LYMPH NODE IN JAW) and FATIGUE (feeling run down). On 28-Jan-2021, the patient experienced PAIN (pain down left side). At the time of the report, VACCINATION SITE PAIN (ARM SORENESS), FATIGUE (FATIGUE), LYMPHADENOPATHY (SWOLLEN LYMPH NODE IN ARM, SWOLLEN LYMPH NODE IN JAW), FATIGUE (feeling run down) and PAIN (pain down left side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Patient is on birth control, diuretic for acne. Treatment details are not provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Extrasystoles, Heart rate increased, Hypertension, Pain in extremity
Clinical narrative: had a rapid heartbeat; blood pressure got high; my heart was skipping beats; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (had a rapid heartbeat), HYPERTENSION (blood pressure got high), PAIN IN EXTREMITY (sore arm) and EXTRASYSTOLES (my heart was skipping beats) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for an unknown indication.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 26-Jan-2021, the patient experienced HEART RATE INCREASED (had a rapid heartbeat), HYPERTENSION (blood pressure got high) and EXTRASYSTOLES (my heart was skipping beats). At the time of the report, HEART RATE INCREASED (had a rapid heartbeat), HYPERTENSION (blood pressure got high), PAIN IN EXTREMITY (sore arm) and EXTRASYSTOLES (my heart was skipping beats) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Blood pressure measurement (120-70): 160/80 (High) Elevated Blood pressure. On 28-Jan-2021, Blood pressure measurement (120-70): 138/80 A little high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  Patient reports she takes blood pressure medicine.
Sex: M
Vaccine: COVID19
Symptoms: Asthenia
Clinical narrative: Little weak; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Little weak) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced ASTHENIA (Little weak). At the time of the report, ASTHENIA (Little weak) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Arm had a knot; Hot to the touch at injection site; Arm  swollen at injection site; Arm was bright red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Arm had a knot), VACCINATION SITE WARMTH (Hot to the touch at injection site), VACCINATION SITE SWELLING (Arm  swollen at injection site) and VACCINATION SITE ERYTHEMA (Arm was bright red) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE MASS (Arm had a knot), VACCINATION SITE WARMTH (Hot to the touch at injection site), VACCINATION SITE SWELLING (Arm  swollen at injection site) and VACCINATION SITE ERYTHEMA (Arm was bright red). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MASS (Arm had a knot), VACCINATION SITE WARMTH (Hot to the touch at injection site), VACCINATION SITE SWELLING (Arm  swollen at injection site) and VACCINATION SITE ERYTHEMA (Arm was bright red) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: injection site was Itching; injection site was swollen; sore arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE PRURITUS (injection site was Itching) and VACCINATION SITE SWELLING (injection site was swollen ) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 31-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (injection site was Itching) and VACCINATION SITE SWELLING (injection site was swollen ). At the time of the report, PAIN IN EXTREMITY (sore arm), VACCINATION SITE PRURITUS (injection site was Itching) and VACCINATION SITE SWELLING (injection site was swollen ) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash, Thermal burn
Clinical narrative: Itchy; Burns; RASH; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy), THERMAL BURN (Burns) and RASH (RASH) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced PRURITUS (Itchy), THERMAL BURN (Burns) and RASH (RASH). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (Itchy), THERMAL BURN (Burns) and RASH (RASH) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: VERTIGO; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (VERTIGO) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VERTIGO (VERTIGO). At the time of the report, VERTIGO (VERTIGO) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Dizziness, Fatigue, Headache, Myalgia
Clinical narrative: Severe dizziness; Headache; Soreness/ body ache; Fatigue; Nausea throwing up; Pain; Confusion; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Severe dizziness), HEADACHE (Headache), MYALGIA (Soreness/ body ache), FATIGUE (Fatigue) and NAUSEA (Nausea throwing up) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Severe dizziness), HEADACHE (Headache), MYALGIA (Soreness/ body ache), FATIGUE (Fatigue), NAUSEA (Nausea throwing up), PAIN (Pain) and CONFUSIONAL STATE (Confusion). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Severe dizziness), HEADACHE (Headache), MYALGIA (Soreness/ body ache), FATIGUE (Fatigue), NAUSEA (Nausea throwing up), PAIN (Pain) and CONFUSIONAL STATE (Confusion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain
Clinical narrative: Severe dizziness; Headache; Soreness/ body ache; Fatigue; Nausea throwing up; Pain; Confusion; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Severe dizziness), HEADACHE (Headache), MYALGIA (Soreness/ body ache), FATIGUE (Fatigue) and NAUSEA (Nausea throwing up) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Severe dizziness), HEADACHE (Headache), MYALGIA (Soreness/ body ache), FATIGUE (Fatigue), NAUSEA (Nausea throwing up), PAIN (Pain) and CONFUSIONAL STATE (Confusion). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Severe dizziness), HEADACHE (Headache), MYALGIA (Soreness/ body ache), FATIGUE (Fatigue), NAUSEA (Nausea throwing up), PAIN (Pain) and CONFUSIONAL STATE (Confusion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Area below the injection site is swollen; Area below the injection site is hot; Area below the injection site is itchy; Area below the injection site is stings; Area below the injection site is red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (Area below the injection site is swollen), INJECTION SITE WARMTH (Area below the injection site is hot), INJECTION SITE PRURITUS (Area below the injection site is itchy), INJECTION SITE PAIN (Area below the injection site is stings) and INJECTION SITE ERYTHEMA (Area below the injection site is red) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced INJECTION SITE SWELLING (Area below the injection site is swollen), INJECTION SITE WARMTH (Area below the injection site is hot), INJECTION SITE PRURITUS (Area below the injection site is itchy), INJECTION SITE PAIN (Area below the injection site is stings) and INJECTION SITE ERYTHEMA (Area below the injection site is red). At the time of the report, INJECTION SITE SWELLING (Area below the injection site is swollen), INJECTION SITE WARMTH (Area below the injection site is hot), INJECTION SITE PRURITUS (Area below the injection site is itchy), INJECTION SITE PAIN (Area below the injection site is stings) and INJECTION SITE ERYTHEMA (Area below the injection site is red) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: HEADACHE; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (HEADACHE) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for an unknown indication.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 27-Jan-2021, the patient experienced HEADACHE (HEADACHE). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 28-Jan-2021, HEADACHE (HEADACHE) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant products were not provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Nodule, Pain, Pruritus, Tenderness
Clinical narrative: soreness; little brown bumps; painful; itchy; inflamed; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (soreness), NODULE (little brown bumps), PAIN (painful), PRURITUS (itchy) and INJECTION SITE SWELLING (inflamed) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TENDERNESS (soreness), NODULE (little brown bumps), PAIN (painful), PRURITUS (itchy) and INJECTION SITE SWELLING (inflamed). At the time of the report, TENDERNESS (soreness), NODULE (little brown bumps), PAIN (painful), PRURITUS (itchy) and INJECTION SITE SWELLING (inflamed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Both of her big toes went numb; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Both of her big toes went numb) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced HYPOAESTHESIA (Both of her big toes went numb). At the time of the report, HYPOAESTHESIA (Both of her big toes went numb) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment details included Anti-inflammatories
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Muscle fatigue
Clinical narrative: Muscle fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE FATIGUE (Muscle fatigue) and CHILLS (Chills) in an 86-year-old male patient who received mRNA-1273 for COVID-19 vaccination.     The patient's past medical history included Heart disorder and Defibrillator/pacemaker insertion since an unknown date.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCLE FATIGUE (Muscle fatigue) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MUSCLE FATIGUE (Muscle fatigue) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Intramuscular) was unknown.       No concomitant medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: warm to the touch; Itchy arm; hard lump on arm; red 4-5 inches in diameter; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE PRURITUS (Itchy arm), VACCINATION SITE SWELLING (hard lump on arm) and VACCINATION SITE ERYTHEMA (red 4-5 inches in diameter) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for Covid-19 Vaccination.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included LISINOPRIL, AMLODIPINE and ALENDRONATE SODIUM (ALENDRONATE).    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE PRURITUS (Itchy arm), VACCINATION SITE SWELLING (hard lump on arm) and VACCINATION SITE ERYTHEMA (red 4-5 inches in diameter). At the time of the report, VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE PRURITUS (Itchy arm) and VACCINATION SITE ERYTHEMA (red 4-5 inches in diameter) outcome was unknown and VACCINATION SITE SWELLING (hard lump on arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Consumer states the discomfort wasn't unbearable but she did take a Zyrtec and iced it to relieve the feeling.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: positive (Positive) Tested positive for COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported No treatment information was provided.; Sender's Comments: Based on the natural history of COVID-19, and the established information about the mRNA-1273 vaccine, a causal association between the event of tested positive for COVID and the product use is assessed as unlikely,
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nausea, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Hot 2 inches area; Dizzy; Nausea; Headache; Itchy 2 inches area; big red 2 inches area; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot 2 inches area), DIZZINESS (Dizzy), VACCINATION SITE ERYTHEMA (big red 2 inches area), NAUSEA (Nausea) and HEADACHE (Headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (big red 2 inches area). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Hot 2 inches area), DIZZINESS (Dizzy), NAUSEA (Nausea), HEADACHE (Headache) and VACCINATION SITE PRURITUS (Itchy 2 inches area). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Hot 2 inches area), DIZZINESS (Dizzy), VACCINATION SITE ERYTHEMA (big red 2 inches area), NAUSEA (Nausea), HEADACHE (Headache) and VACCINATION SITE PRURITUS (Itchy 2 inches area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details included ice pack  for symptoms.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Hot 2 inches area; Dizzy; Nausea; Headache; Itchy 2 inches area; big red 2 inches area; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot 2 inches area), DIZZINESS (Dizzy), VACCINATION SITE ERYTHEMA (big red 2 inches area), NAUSEA (Nausea) and HEADACHE (Headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (big red 2 inches area). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Hot 2 inches area), DIZZINESS (Dizzy), NAUSEA (Nausea), HEADACHE (Headache) and VACCINATION SITE PRURITUS (Itchy 2 inches area). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Hot 2 inches area), DIZZINESS (Dizzy), VACCINATION SITE ERYTHEMA (big red 2 inches area), NAUSEA (Nausea), HEADACHE (Headache) and VACCINATION SITE PRURITUS (Itchy 2 inches area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details included ice pack  for symptoms.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: fever; body aches; headaches; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PYREXIA (fever), MYALGIA (body aches) and HEADACHE (headaches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), MYALGIA (body aches) and HEADACHE (headaches). At the time of the report, PYREXIA (fever), MYALGIA (body aches) and HEADACHE (headaches) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Injection site pain, Pyrexia
Clinical narrative: High Fever 100 degrees; Sore arm (injection site); Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of   in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Body temperature: 100 (High) 100 degree.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 03-Feb-2021, the patient experienced high fever of 100  degrees, sore arm at injection site, headache and chills. Concomitant medications were not provided. Treatment information was not reported.
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: contracted covid on 1-24-2021; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (contracted covid on 1-24-2021) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20a) for COVID-19 immunisation.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (contracted covid on 1-24-2021). At the time of the report, SARS-COV-2 TEST POSITIVE (contracted covid on 1-24-2021) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jan-2021, SARS-CoV-2 test positive: positive (abnormal) POSITIVE.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not reported.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Received the vaccine and got a hot temperature; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Received the vaccine and got a hot temperature) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Received the vaccine and got a hot temperature). At the time of the report, PYREXIA (Received the vaccine and got a hot temperature) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Hypersensitivity, Vaccination site erythema, Vaccination site pruritus, Wrong technique in product usage process
Clinical narrative: Tiny bruise; almost like an allergic reaction; nurse squeezed her arm when she was getting the vaccine; red spot belowher vaccination that was about 5 inches long and 3 inches wide. It was itchy; red patch on arm, red spot below her vaccination that was about 5 inches long and 3 inches wide; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CONTUSION (Tiny bruise), HYPERSENSITIVITY (almost like an allergic reaction), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (nurse squeezed her arm when she was getting the vaccine), VACCINATION SITE PRURITUS (red spot belowher vaccination that was about 5 inches long and 3 inches wide. It was itchy) and VACCINATION SITE ERYTHEMA (red patch on arm, red spot below her vaccination that was about 5 inches long and 3 inches wide) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced CONTUSION (Tiny bruise), HYPERSENSITIVITY (almost like an allergic reaction), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (nurse squeezed her arm when she was getting the vaccine), VACCINATION SITE PRURITUS (red spot belowher vaccination that was about 5 inches long and 3 inches wide. It was itchy) and VACCINATION SITE ERYTHEMA (red patch on arm, red spot below her vaccination that was about 5 inches long and 3 inches wide). The patient was treated with HYDROCORTISONE for Vaccination site erythema, at an unspecified dose and frequency. On 21-Jan-2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (nurse squeezed her arm when she was getting the vaccine) had resolved. At the time of the report, CONTUSION (Tiny bruise) and HYPERSENSITIVITY (almost like an allergic reaction) outcome was unknown and VACCINATION SITE PRURITUS (red spot belowher vaccination that was about 5 inches long and 3 inches wide. It was itchy) and VACCINATION SITE ERYTHEMA (red patch on arm, red spot below her vaccination that was about 5 inches long and 3 inches wide) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 31-jan-2021, the patient reported that red spot below her vaccination seemed to be worse, a little bit redder. It was still the same size. On 01-Feb-2021, it itches a little. It seems to be a little bit smaller area. She was surprised that it did not occur until the following Friday, which was 8 days. She called her daughter, who was a nurse. The nurse squeezed her arm when she was getting the vaccine. Her daughter said they really should not be squeezing her arm. It was almost like if you get an allergic reaction, and it itches, a little bit bumpy and it was red.
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: tested positive for COVID; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for COVID) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for COVID). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for COVID) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Jan-2021, SARS-CoV-2 test: positive (abnormal) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided. The patient was asymptomatic as reported by the health care professional.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain
Clinical narrative: armpit pain; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (armpit pain) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced AXILLARY PAIN (armpit pain). At the time of the report, AXILLARY PAIN (armpit pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: After the shot, the nausea increased; Has throwed up 3 times by the day; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (After the shot, the nausea increased) and VOMITING (Has throwed up 3 times by the day) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Kidney stone and Nausea. Concomitant products included METFORMIN, LOVASTATIN, ATORVASTATIN CALCIUM (LIPITOR), POTASSIUM CHLORIDE (POTASSIUM [POTASSIUM CHLORIDE]), LISINOPRIL, MULTIVITAMINS [VITAMINS NOS], VITAMIN B12 [VITAMIN B12 NOS] and DULAGLUTIDE (TRULICITY) for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced NAUSEA (After the shot, the nausea increased) and VOMITING (Has throwed up 3 times by the day). At the time of the report, NAUSEA (After the shot, the nausea increased) had not resolved and VOMITING (Has throwed up 3 times by the day) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient received unspecified treatment medication for nausea.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Itching at injection site on and off; Rash in area of injection/ Pinkish in color rash; Some heat coming out when I touch it at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at injection site on and off), VACCINATION SITE RASH (Rash in area of injection/ Pinkish in color rash) and VACCINATION SITE PAIN (Some heat coming out when I touch it at injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O29620A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at injection site on and off), VACCINATION SITE RASH (Rash in area of injection/ Pinkish in color rash) and VACCINATION SITE PAIN (Some heat coming out when I touch it at injection site). At the time of the report, VACCINATION SITE PRURITUS (Itching at injection site on and off) was resolving and VACCINATION SITE RASH (Rash in area of injection/ Pinkish in color rash) and VACCINATION SITE PAIN (Some heat coming out when I touch it at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The patient put cold compressor to relieve the symptoms.
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Pain, Peripheral swelling, Pruritus, Rash
Clinical narrative: Soreness; Facial flushing; She could not get her rings off on her left hand; Rash that has spread; Arm irritation to the touch; Itching; Hotness at the injection site; Redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hotness at the injection site), PRURITUS (Itching), SKIN IRRITATION (Arm irritation to the touch), PAIN (Soreness) and FLUSHING (Facial flushing) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J209) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Hotness at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). On 28-Jan-2021, the patient experienced PRURITUS (Itching). On 29-Jan-2021, the patient experienced SKIN IRRITATION (Arm irritation to the touch) and RASH (Rash that has spread). On 30-Jan-2021, the patient experienced PAIN (Soreness), FLUSHING (Facial flushing) and PERIPHERAL SWELLING (She could not get her rings off on her left hand). At the time of the report, VACCINATION SITE WARMTH (Hotness at the injection site), PRURITUS (Itching), SKIN IRRITATION (Arm irritation to the touch), PAIN (Soreness), FLUSHING (Facial flushing), PERIPHERAL SWELLING (She could not get her rings off on her left hand) and RASH (Rash that has spread) had not resolved and VACCINATION SITE ERYTHEMA (Redness at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Skin irritation, Vaccination site erythema, Vaccination site warmth
Clinical narrative: Soreness; Facial flushing; She could not get her rings off on her left hand; Rash that has spread; Arm irritation to the touch; Itching; Hotness at the injection site; Redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hotness at the injection site), PRURITUS (Itching), SKIN IRRITATION (Arm irritation to the touch), PAIN (Soreness) and FLUSHING (Facial flushing) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J209) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Hotness at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). On 28-Jan-2021, the patient experienced PRURITUS (Itching). On 29-Jan-2021, the patient experienced SKIN IRRITATION (Arm irritation to the touch) and RASH (Rash that has spread). On 30-Jan-2021, the patient experienced PAIN (Soreness), FLUSHING (Facial flushing) and PERIPHERAL SWELLING (She could not get her rings off on her left hand). At the time of the report, VACCINATION SITE WARMTH (Hotness at the injection site), PRURITUS (Itching), SKIN IRRITATION (Arm irritation to the touch), PAIN (Soreness), FLUSHING (Facial flushing), PERIPHERAL SWELLING (She could not get her rings off on her left hand) and RASH (Rash that has spread) had not resolved and VACCINATION SITE ERYTHEMA (Redness at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.